PRKN and Alzheimer disease: A triple-transgenic AD (3xTg AD) mouse model injected with lentiviral parkin showed increased ubiquitination and clearance of intracellular Aβ aggregates, with a concomitant reduction of extracellular Aβ plaques (Khandelwal et al., 2011).